Kawaljit Kaur

About Kawaljit Kaur

An experienced scientist with extensive expertise in translational, clinical, and medical research, specializing in NK cell- and CD8+ T cell-based immunotherapy. With over 20 years in healthcare, deeply dedicated to aiding patients with cancer, autoimmune diseases, neurodegenerative disorders, and aging populations worldwide. Proven abilities include completing clinical trials, developing innovative cell-based immunotherapies currently used to treat cancer patients, and creating diagnostic analyses for cancer and autoimmune diseases.Email: d••••••••@g.ucla.eduA scientist with a strong understanding of immune cell biology and mechanisms of action in health and diseases, her work includes 15+ patents, 2 clinical trials, 105 scientific articles, 12 book chapters, recognition as a guest/review editor in 30+ scientific journals, 3 foundations, and 20+ collaborations.CORE COMPETENCIES- Immunology- Cancer Immunotherapy- NK cells- T cells- Cell sorting and expansion- Clinical Trials- Supervisor/leadership - Scientific writer/editorAccomplishments- Generated preclinical work and transferred that to clinical trials to treat cancer patients- My Ph.D. studies established a novel technology to supercharge NK cells as cancer therapeutics.

Experience

1. Director

   Cure Cancer Now Foundation

   Jun 2017 — Present · Los Angeles, CA, US

   CURE CANCER NOW OBJECTIVES1. Ensure adequate funding for cancer research by raising awareness among the population regarding the inadequacies in funding and the future of cancer research, in addition to actively raising funds to support cancer research.2. Ensure accountability of cancer researchers to individuals or entities who support the research by providing frequent progress reports.3. Provide acknowledgments of contribution to those who support the research.4. Establish strategic alliances between cancer researchers and funding entities to expedite cancer research.5. Accelerate the development of cancer treatments by funding basic research with potential to apply to patients (translational research).6. Increase communication between basic scientists and clinical practitioners.7. Provide incentives and ensure adequate support for the training and development of future cancer researchers8. Establish successful fund-raising activities by recruiting fund-raising professionals to the board.9. Establish a panel of basic and clinical scientists who will carry out the mission and the objectives of the foundation in addition to serving as reviewers for the submitted grants.10. Find and support cutting edge cancer research. Provide recommendations, suggestions and corrections for submitted grants.11. Seek corporate partnerships and alliances in raising funds.12. Organize regular meetings to discuss strategies to improve the function of the foundation.13. Dedicate manuscripts to patients who so graciously and courageously fight against cancer so that the scientists who usually carry the work in the laboratories and do not have contact with the patients realize that behind each work there stands a patient who is desperately waiting for a cure. In other words instill a sense of urgency in scientists to speed the process of discoveries.14. Dedicate manuscripts to those contributing financially to cancer research

Education

• David Geffen School of Medicine at UCLA

  Doctor of Philosophy - PhD, Immunology/Cancer Immunotherapy

  2015 — 2017

• Alexandra school Amritsar, Punjab , India

  High School

  1995 — 1999

• UCLA School of Dentistry

  Doctor of Philosophy (PhD), Oral Biology and Oral Medicine

  2015 — 2017

• Baba farid university, faridkot, INDIA

  Bachelor's degree, Dentistry

  2003 — 2009

• Shri Guru Harkrishan public school, India

  School

  1995

• Khalsa college Amritsar, India

  Medical Science

  2000 — 2002

• UCLA

  M.S, Oral Biology and Medicine

  2013 — 2015